Clinical Trial Update: Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers [NA]

View source ↗

Summary

A postmarket study is underway to evaluate Biovance for the treatment of diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Biovance

Snippet

Sponsor: Alliqua BioMedical, Inc | Conditions: Diabetic Foot Ulcers | NA | Status: UNKNOWN